Tag Archives: OPKO Health

January, 2018

July, 2016

  • 1 July

    OPKO Health Acquires Transition Therapeutics

    MIAMI & TORONTO–(BUSINESS WIRE)– OPKO Health, Inc. (NASDAQ:OPK) and Transition Therapeutics Inc. (NASDAQ:TTHI, TSX:TTH) announce the signing of a definitive agreement under which OPKO will acquire Transition Therapeutics, a clinical stage biotechnology company. Under the terms of the agreement approved by the Boards of Directors of both companies, Transition Therapeutics …

June, 2016

December, 2015

October, 2015

  • 14 October

    Opko Health and Vanderbilt Collaborate on Genomics Testing

    MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE:OPK) announced today a collaboration among its subsidiary, BioReference Laboratories, Inc., the Department of Pathology, Microbiology, and Immunology and the Vanderbilt-Ingram Cancer Center (VICC) at Vanderbilt University Medical Center (VUMC) to leverage large scale genomics testing for optimal cancer care. Each of the organizations has committed …